glp-1 weight loss research drugs leave users low on key nutrients, study finds GLP-1s have transformed weight loss

They typically settle down as your body adjusts - and the standard approach of starting at a low dose and titrating up gradually over weeks is specifically designed to reduce how rough that adjustment is

LEAD-6 Study Group

Some have been serious, including vomiting, abdominal pain, and diarrhea

In June 2024, the company announced a new $4.1 billion manufacturing site in Clayton, North Carolina, on a 56-acre campus ( [5] )

These drugs are primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities

Novo Nordisks Response to JAMA Study and Allegations In an emailed statement, Wegovy manufacturer Novo Nordisk countered that there were several limitations of the JAMA study design, which was not a randomized controlled trial, as reported by Reuters